Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyoscine Butyl Bromide for Adenoma Detection Rate in Colonoscopy
NCT01609855Phase 4Unknown
- Sponsor
- Valduce Hospital
- Start
- Jan 2012
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hyoscine butylbromide in Colonic adenoma, sponsored by Valduce Hospital. Status: unknown.
02
Drugs
hyoscine butylbromide
03
Conditions
Colonic adenoma
Beyond the preview
Go deeper on NCT01609855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01609855.